Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial

Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial

(2014) Pascal Vranckx et al.   EUROPEAN HEART JOURNAL

2014 ESC/EACTS Guidelines on myocardial revascularization

(2014)   EUROPEAN HEART JOURNAL

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

(2014) Laura Mauri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: A meta-analysis of randomized trials

(2013) Marco Valgimigli et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

(2013) Gregg W Stone et al.   LANCET

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

(2012) Marco Valgimigli et al.   CIRCULATION

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

(2012) et al.   CIRCULATION

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

(2012) et al.   CIRCULATION

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction

(2012) Bindu Kalesan et al.   EUROPEAN HEART JOURNAL

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)

(2011) Marco Valgimigli et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention

(2010) Marco Valgimigli et al.   AMERICAN HEART JOURNAL

Predictors and Impact of Bleeding Complications in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial Infarction

(2009) Steven V. Manoukian   AMERICAN JOURNAL OF CARDIOLOGY